Given the numbers of diversity in clinical trials, regulators and sponsors are trying to broaden the recruitment of people from different racial and ethnic groups. But one thing is missing: a clear explanation of why this is important.
Given the numbers of diversity in clinical trials, regulators and sponsors are trying to broaden the recruitment of people from different racial and ethnic groups. But one thing is missing: a clear explanation of why this is important.